RecruitingNCT05402839
Screening of Malignant Hyperthermia Susceptible Individuals
Studying Malignant hyperthermia of anesthesia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Peking University Third Hospital
- Enrollment
- 50 target
- Eligibility
- 0-100 years · All sexes
- Timeline
- 2022 – 2041
Study locations (1)
- Peking University Third Hospital, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05402839 on ClinicalTrials.gov